Kangji Medical Holdings Limited
HKSE 9997.HK
Kangji Medical Holdings Limited Operating Cash Flow for the year ending December 31, 2023: USD 59.10 M
-
Kangji Medical Holdings Limited Operating Cash Flow for the year ending December 31, 2022 was USD 46.27 M, a -32.53% change year over year.
-
Kangji Medical Holdings Limited Operating Cash Flow for the year ending December 31, 2021 was USD 68.58 M, a 102.51% change year over year.
-
Kangji Medical Holdings Limited Operating Cash Flow for the year ending December 31, 2020 was USD 33.86 M, a -27.63% change year over year.
-
Kangji Medical Holdings Limited Operating Cash Flow for the year ending December 31, 2019 was USD 46.79 M, a 57.18% change year over year.
| Date | Operating Cash Flow | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities | Dividends Paid |
|---|
Don’t Miss A Beat
| CEO | Mr. Ming Zhong |
| IPO Date | June 29, 2020 |
| Location | China |
| Headquarters | Tonglu Economic Development Zone |
| Employees | 964 |
| Sector | Healthcare |
| Industries | |
Kangji Medical Holdings Limited, through its subsidiaries, designs, develops, manufactures, and sale of minimally invasive surgical instruments and accessories in China. It offers disposable trocars, polymer ligation clips, disposable electrocoagulation forceps, ultrasonic scalpels, and other types of disposable hand-held instruments; and reusable trocars, reusable forceps, and other reusable products. The company's products are used in obstetrics and gynecology, general surgery, urology, and thoracic surgery specialties. It primarily sells products to a network of distributors. The company was founded in 2004 and is headquartered in Hangzhou, China.
Past 5 years
USD 0.48
StockViz Staff
February 10, 2025
Any question? Send us an email